Invention Grant
- Patent Title: Polynucleotides encoding anti-CD40 antibodies
-
Application No.: US15991432Application Date: 2018-05-29
-
Publication No.: US10561728B2Publication Date: 2020-02-18
- Inventor: Keith A. Reimann , Rijian Wang , Christian P. Larsen
- Applicant: Beth Israel Deaconess Medical Center, Inc. , Emory University
- Applicant Address: US MA Boston US GA Atlanta
- Assignee: Beth Israel Deaconess Medical Center, Inc.,Emory University
- Current Assignee: Beth Israel Deaconess Medical Center, Inc.,Emory University
- Current Assignee Address: US MA Boston US GA Atlanta
- Agency: Clark & Elbing LLP
- Main IPC: C12N15/13
- IPC: C12N15/13 ; C12N15/12 ; C12N15/63 ; A61K39/395 ; A61K38/13 ; A61K45/06 ; A61K31/436 ; C07K16/28 ; A61P37/06 ; C07K16/18 ; A61K39/00
Abstract:
The present invention relates to antibodies specific for a particular epitope on CD40 and antibodies that bind CD40 and have particular functional characteristics. The present invention also relates to fragments of these antibodies, uses of the antibodies for reduction or treatment of transplant rejection and graft-versus-host disease, and methods for making the antibodies.
Public/Granted literature
- US20180344845A1 ANTI-CD40 ANTIBODIES AND USES THEREOF Public/Granted day:2018-12-06
Information query
IPC分类:
